A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during COVID-19
- PMID: 36445113
- DOI: 10.1111/bju.15939
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during COVID-19
References
-
- Tamhankar AS, El-Taji O, Vasdev N, Foley C, Popert R, Adshead J. The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of hospital episode statistics data 2008-2019. BJU Int 2020; 126: 133-41
-
- EAU Guidelines on Prostate Cancer. Presented at the EAU Annual Congress Amsterdam 2022, 2022
-
- Nossiter J, Morris M, Parry MG et al. Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer. BJU Int 2022; 130: 262-70
-
- British Association of Urological Surgeons (BAUS). COVID-19 Strategy for the Interim Management of Prostate Cancer. BAUS Section of Oncology, 2020
-
- Ribal MJ, Cornford P, Briganti A et al. European Association of Urology guidelines office rapid reaction group: an organisation-wide collaborative effort to adapt the European Association of Urology guidelines recommendations to the coronavirus disease 2019 era. Eur Urol 2020; 78: 21-8
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical